Seven exoribonucleases, distinct both genetically and biochemically, are now known to be present in Escherichia coli (3) . Important questions that are raised by this unexpected multiplicity of RNases are whether each of the enzymes has a separate primary function in vivo, whether some serve as backup enzymes when others are absent, and how extensive the overlap in their specificities is. Earlier studies showed that mutations eliminating only a single exoribonuclease have little or no effect on growth (reviewed in references 2 and 3), indicating that for every one of these enzymes there is an alternate RNase that can effectively take over any of their required functions. Even certain multiple combinations of RNase mutations have only relatively minor growth defects (10, 11) . Thus, a strain devoid of the exoribonucleases RNase II, D, BN, and T, as well as the nonspecific endoribonuclease RNase I, grows only slightly more slowly than the wild type (10) . On the other hand, certain other combinations of mutations, such as in RNase II and polynucleotide phosphorylase (PNP) (6) or in RNase PH and PNP (7), can have major effects on growth.
We have recently shown that introduction of a null mutation in the rph gene, encoding RNase PH, into the aforementioned RNase I-11-D-BN-T-strain leads to an inviable phenotype (7) . This finding has provided us with a system to determine the degree of functional overlap in vivo among the five exoribonucleases RNase II, D, BN, T, and PH. To accomplish this, we have constructed strains in which only one of the five enzymes is still present and have examined the growth properties of the individual strains. Our results indicate that any one of the five exoribonucleases is sufficient to maintain viability of E. coli cells but that their growth properties vary widely. These results demonstrate a surprisingly high degree of functional overlap among these enzymes in vivo.
E. coli cells containing only one of the five exoribonucleases under study were constructed by phage Pl-mediated transduction. Strain CAN20-12E mt::kan, lacking RNases I, II, D, BN, and T, and strain CAN20-12E/18-11, lacking RNases I, II, D, and BN and containing 30% of RNase T (T+/-), were previously described (5, 9) ; the former strain served as the RNase PH+ cell. This strain was transduced to * Corresponding author. RNase BN as the only one of the five exoribonucleases was made from strain CA265/3-1 (RNase II-D-) (4) by introduction of rnt::kan and rph::cam. The ma mutation was introduced by using a nearby TnlO after first converting the strain to Tcs and assaying Tcr transductants for RNase I activity. The mutations in md, mt, and rph are null mutations, whereas those in mb and rbn (RNase BN) have not been characterized structurally but display very low levels of activity of the relevant enzyme (1% or less, on the basis of enzyme assay or ability to plate phage).
The identities of the multiple-RNase-deficient strains were confirmed by assay of extracts for each of the five RNase activities under study. The substrates used for the assays were as follows: RNase II, Pi-dependent activity was determined. Conditions for the various assays were as described previously (4, 9) and in Table 1 , footnote a.
The data in Table 1 show that for each of the multipleRNase-deficient strains the RNase activities are as expected.
Thus, for four of the strains (T+, PH+, D+, and II'), the one RNase in each expected to be at a high level does display a level of activity close to that of the wild type on the appropriate substrate, whereas levels of activity against all the other substrates are much lower. However, it is also evident that the mutant extracts can have considerable activity against other tRNA substrates, indicating a considerable amount of overlap in substrate specificity, as is already known (10) . In contrast, RNase II is the only RNase that acts on poly(A) to a significant degree, and RNase PH is the only enzyme of the five that displays a significant level of Pi-dependent activity.
The identity of the BN+ strain could not be confirmed by assay alone because all the RNases act on the substrates for RNase BN, tRNA-CA or tRNA-CU, to some degree, and RNase BN has a relatively low level of activity (11) . Never-NOTES From the foregoing discussion of strain construction and assay of RNase activities, it is evident that while cells lacking the five exoribonucleases do not survive (7), cells containing only one of the five are viable. In fact, a strain lacking RNases I, II, D, BN, and PH and 70% of RNase T is viable as well (Table 2) . Thus, each one of the five exoribonucleases has sufficient breadth of specificity in vivo to take over the functions and substitute for the other four missing enzymes.
To determine the relative effectiveness with which each of the RNases can substitute for all five of the enzymes, we determined the growth rate of each of the strains containing only a single exoribonuclease. As shown in Table 2 , although any one of the RNases can support growth, they do so with very different efficiencies. On the basis of this criterion, RNase T has the broadest specificity, maintaining a cell doubling time of 35 min compared with 24 min for the wild-type strain containing all of the RNases. Even a cell with only 30% of the normal level of RNase T maintains relatively effective growth, doubling every 57 min. It should be noted that RNase T is the only one of the five exoribo- c Taken from reference 7. nucleases whose removal by a single mutation does affect growth (10) . Thus, although RNase T can substitute reasonably well when all four of the other RNases are missing, the other four enzymes, even in combination, cannot completely take over the role of RNase T.
For the other four exoribonucleases, their order of effectiveness in supporting growth is as follows: RNase PH > RNase D > RNase II > RNase BN. For the most slowly growing strain, the BN+ strain, measurement of accurate doubling times was difficult because of the tendency of this cell to revert to a faster-growing form. The value reported is for the lowest growth rate observed in several growth experiments. The nature of the change(s) resulting in faster growth is presently unknown, but analysis of the possible suppressor mutation(s) will be of considerable interest.
The data presented here demonstrate that any one of the five exoribonucleases is sufficient to overcome the nogrowth phenotype of an RNase 1-II-D-BN-T-PH-cell, indicating a high degree of functional overlap among these enzymes in vivo. However, the enzymes vary considerably in their ability to support growth, as would be expected from the different substrate specificities of these enzymes in vitro (3) . Nevertheless, this situation is quite different from that observed with genes encoding some of the E. coli endoribonucleases in which single mutations can have profound effects on cell growth (2) . Why E. coli requires the presence of so many exoribonucleases is unclear. Presumably, there are certain situations encountered in nature, which are not reproduced by the growth in rich media in the laboratory, for which the presence of all of these enzymes provides a selective advantage.
Finally, it should be noted that two other exoribonucleases, PNP and RNase R, are known to be present in E. coli (2, 3) . Clearly, these two enzymes by themselves are not sufficient to support the growth of a cell. However, they may contribute to the ability of the strains containing one of the five remaining exoribonucleases to grow, especially if the substrate specificities of PNP and RNase R complement that of the other RNase. Examination of the properties of strains containing additional combinations of mutations, including those in genes encoding PNP 
